Albumin & Creatinine Tests Market Analysis and Forecast to 2031: By Product (Dipsticks & Kits, Analyzers, Cartridges, Reagents), Type (Urine Tests, Blood & Serum Creatinine Tests), End User (Hospitals & Clinics, Diagnostic Laboratories, Research Laborator

Albumin & Creatinine Tests Market Analysis and Forecast to 2031: By Product (Dipsticks & Kits, Analyzers, Cartridges, Reagents), Type (Urine Tests, Blood & Serum Creatinine Tests), End User (Hospitals & Clinics, Diagnostic Laboratories, Research Laboratories & Institutes) and Region

Global Albumin & Creatinine Tests Market is expected to reach $3.6 bn by 2031 growing at a CAGR of 14.7% between 2021 and 2031.

The urine albumin to creatinine ratio test is a common way to screen for high levels of albumin, which is known as albuminuria. This screening is most often done on people who have a greater risk of kidney disease comprising people with diabetes, high blood pressure, or a family history of kidney problems. Screening may also be recommended in older adults and people in some racial and ethnic groups. Screening for kidney disease may combine a urine albumin test with another kidney function test, known as an estimated glomerular filtration rate (eGFR) test, that assesses how well the kidneys are filtering the blood.

Scope of the Report

Market DriversRising prevalence of kidney disorders

Kidney disease is one of the major causes of death worldwide. Such cases—comprising multiple kidney treatments—require the continuous monitoring of components such as creatinine and albumin and their ratios, for which multiple urine analysis products and techniques are utilized. Urine analysis has extensive applications in the diagnosis and management of kidney diseases. Biochemical urine analysis enables clinicians to assess the level of chemical compounds (such as creatinine, urobilinogen, bilirubin, ketones, and glucose) in the urine. Atypical levels of these compounds in the urine indicate chronic kidney diseases, acute kidney injuries, and acute renal failure. So, the growing incidence of kidney diseases will be the primary growth driver for this market, as it will ensure sustained demand for albumin and creatinine tests.

Market OpportunityIntegrated and automated systems for overall urine analysis

The combination of automated urine sediment and urine biochemical analysis in one system allows rapid and easy urine analysis. Currently, standalone automated urine sediment analyzers help standardize sediment & biochemical analysis with minimum operator interference and enable the fast analysis of urine samples. Such integrated systems have a high potential in the automated devices market and can help large hospitals and diagnostic labs to manage their workloads ecologically. Owing to that, this area has been identified as an opportunity in the market.

Market RestraintsHigh cost of automated analyzers

Most small hospitals and clinics with lower workloads still prefer semi-automated devices or manual analysis. Automated devices are primarily used by large hospitals with higher workloads; so, the revenue generation can justify the costs incurred in installing automated analyzers. This makes it difficult for automated analyzers to penetrate the market, specifically in developing economies, which is a major restraint factor to market growth.

Impact of COVID-19 on Albumin & Creatinine Tests Market

Acute Renal Failure (ARF) is generally detected and confirmed by increased creatinine levels in the urine, coupled with a sudden drop in the urine output. Adding to that, the rise in and high rate of hypoalbuminemia caused by COVID-19 (coupled with the rising geriatric population and other factors) is likely to increase the cases of AKI/ARF and thus support the market growth during the early half of the projection period.

Market Segmental Analysis

The global albumin and creatinine tests market is segmented into product, type, and end-user.

Global Albumin & Creatinine Tests Market by Product

The global albumin & creatinine tests market is comprised of various products such as dipsticks & kits, analyzers, cartridges, reagents & other consumables. The cartridges segment is also sub-segmented into cartridges for POC analyzers and cartridges for the table-top analyzers.

The dipstick & kits segment is likely to dominate the market during the forecast period at a constant rate of XX%. The key factors such as frequent purchasing of these products coupled with increasing use of kits based on rapid techniques for albumin & creatinine tests are likely to boost the growth of the market.

Global Albumin & Creatinine Tests Market by Type

Based on type, the global albumin & creatinine tests market is segmented into the urine tests, and blood and serum creatinine tests. The urine test segment is also sub-segmented into urine albumin tests, urine creatinine tests and glycated albumin.

The urine tests segment is accounted for the largest share in the market at a CAGR of XX% during the forecast period. The various factors such as rapid growth in the diagnostic segment combined with the increasing demand for rapid and easy-to-use urine tests is likely to propel the growth of the market.

Global Albumin & Creatinine Tests Market by End Users

The global albumin & creatinine tests market is comprised of various end-user such as hospitals & clinics, diagnostic laboratories, research laboratories & institutes.

The hospitals & clinics segment is likely to dominate the market during the forecast period at a constant rate of XX%. The key factors such as a large number of treatment procedures conducted in hospitals and the availability of reimbursement are boosting the growth of the market.

Geographic Analysis of Global Albumin & Creatinine Tests Market

The global albumin & creatinine tests market is studied for various key countries of regions such as North America, Europe, Asia Pacific, and the Rest of the World.

North America is likely to dominate the market during the forecast period. The key factors such as the rise in demand for rapid urine tests coupled with the increasing prevalence of chronic conditions leading to certain kidney diseases, growing government initiatives, and a growing geriatric population is propelling the growth of the region.

Market Players of Global Albumin & Creatinine Tests Market

Key Developments in Global Albumin & Creatinine Tests Market

• August 2020: Sysmex America, Inc. and Siemens Healthcare Diagnostics Inc., signed a distribution agreement that gives Sysmex America an exclusive right to distribute Siemens’ urine chemistry analyzers and their reagents for hospitals and reference laboratory use in the North American market.
• July 2018: Beckman Coulter and U.S. ARKRAY, Inc. announced a new partnership and the launch of the iQ Urinalysis Workcell. The iQ Workcell pairs two of the world’s most regarded automated urine analyzers.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.